232 related articles for article (PubMed ID: 7767665)
1. Fibrinogen and cardiovascular disorders.
Lip GY
QJM; 1995 Mar; 88(3):155-65. PubMed ID: 7767665
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen and cardiovascular risk.
Heinrich J; Assmann G
J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
[TBL] [Abstract][Full Text] [Related]
3. [Recent progress in the "fibrinogen hypothesis"].
Lefebvre P; Ledent T; Ducobu J
Rev Med Brux; 2003 Apr; 24(2):82-7. PubMed ID: 12806874
[TBL] [Abstract][Full Text] [Related]
4. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
Halvorsen S
Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic factors and risk of cardiovascular disease in women. An overview.
Meilahn EN
Arch Pathol Lab Med; 1992 Dec; 116(12):1313-7. PubMed ID: 1456877
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
[TBL] [Abstract][Full Text] [Related]
7. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
Vayá A; Simó M; Santaolaria M; Carrasco P; Corella D
Thromb Res; 2007; 120(4):489-95. PubMed ID: 17215030
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and factor VII as risk factors in vascular disease.
Hultin MB
Prog Hemost Thromb; 1991; 10():215-41. PubMed ID: 2008532
[No Abstract] [Full Text] [Related]
9. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
Welsh P; Woodward M; Rumley A; Lowe G
Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
[TBL] [Abstract][Full Text] [Related]
10. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Conway DS; Buggins P; Hughes E; Lip GY
J Am Coll Cardiol; 2004 Jun; 43(11):2075-82. PubMed ID: 15172416
[TBL] [Abstract][Full Text] [Related]
11. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Ernst E
Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
[TBL] [Abstract][Full Text] [Related]
13. Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
Palmieri V; Celentano A; Roman MJ; de Simone G; Best L; Lewis MR; Robbins DC; Fabsitz RR; Howard BV; Devereux RB;
Am Heart J; 2003 Mar; 145(3):467-74. PubMed ID: 12660670
[TBL] [Abstract][Full Text] [Related]
14. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
15. Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events.
Sechi LA; Zingaro L; Catena C; De Marchi S
Thromb Haemost; 2000 Oct; 84(4):565-70. PubMed ID: 11057851
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinogen: cardiovascular risk factor].
Espinosa RA;
Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
[TBL] [Abstract][Full Text] [Related]
17. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
18. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
Catena C; Cavarape A; Dotto L; Colussi G; Novehllo M; De Marchi S; Sechi LA
Adv Clin Path; 2003 Jan; 7(1):3-11. PubMed ID: 19774732
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study.
Aono Y; Ohkubo T; Kikuya M; Hara A; Kondo T; Obara T; Metoki H; Inoue R; Asayama K; Shintani Y; Hashimoto J; Totsune K; Hoshi H; Satoh H; Izumi S; Imai Y
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):963-8. PubMed ID: 17272746
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.
de la Serna G
J Fam Pract; 1994 Nov; 39(5):468-77. PubMed ID: 7964545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
